
NeurologyLive® Brain Games: November 22, 2026
Key Takeaways
- A weekly Sunday-morning quiz format delivers three physician- and expert-authored questions integrating clinical and historical neurology content.
- Coverage spans core neurologic domains, including dementia, epilepsy, migraine, movement disorders, multiple sclerosis, neuromuscular, sleep, and cerebrovascular disease.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuro-oncology!
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
This week's questions includes the theme of neuro-oncology!
Interested in submitting quiz questions? Contact our editor, Marco Meglio, via email:
The landmark 2005 EORTC/NCIC phase 3 trial led by Stupp et al. established which regimen as the standard of care for newly diagnosed glioblastoma after maximal safe resection?
Under the 2021 WHO Classification of Tumors of the Central Nervous System (WHO CNS5), the diagnosis of glioblastoma in adults is restricted to tumors with which molecular status?
Vorasidenib, approved by the FDA in August 2024 for grade 2 astrocytoma and oligodendroglioma, targets which molecular alteration?
How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!
How many questions did you get correct?
Related to this article








